Abao, Farisha G.
HRN: 24-47-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2024
AMPICILLIN 1GM (VIAL)
02/01/2024
02/08/2024
IV
300mg
Q6hours
PCAP-C; R/O PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes